Novel biomarkers for immunotherapy: from the results of phase I and II study of five therapeutic peptides for advanced colorectal cancer.

Shoichi Hazama,Norihiro Tanaka,Yuka Inoue,Shinsuke Kanekiyo,Yoshitaro Shindo,Nobuaki Suzuki,Shigeru Takeda,Tomio Ueno,Shigeru Yamamoto,Shigefumi Yoshino,Yusuke Nakamura,Fumiaki Sugiura,Kiyotaka Okuno,Tomonobu Fujita,Yutaka Kawakami,Hiroaki Nagano

Novel biomarkers for immunotherapy: from the results of phase I and II study of five therapeutic peptides for advanced colorectal cancer.

2016

Shoichi Hazama
Norihiro Tanaka
Yuka Inoue
Shinsuke Kanekiyo
Yoshitaro Shindo
Nobuaki Suzuki
Shigeru Takeda
Tomio Ueno
Shigeru Yamamoto
Shigefumi Yoshino
Yusuke Nakamura
Fumiaki Sugiura
Kiyotaka Okuno
Tomonobu Fujita
Yutaka Kawakami
Hiroaki Nagano

e14507Background: Biomarkers to predict the efficacy of immunotherapy have been awaited. A phase I/II study of five therapeutic epitope-peptides for advanced colorectal cancer (CRC) using five nove...

Keywords:

Pathology
Cancer research
Colorectal cancer
Immunotherapy
Biomarker (medicine)
Medicine
Oncology
advanced colorectal cancer
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations